<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Diarrhea]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/diarrhea</link>
    <description><![CDATA[Diarrhea]]></description>
    <pubDate>Sat, 11 Jul 2026 17:48:10 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players]]></title>
      <link>https://www.leadingmarketresearch.com/travelers-diarrhea-drugs-in-development-by-stages-target-moa-roa-molecu</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Traveler&#039;s Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Traveler&#039;s Diarrhea pipeline landscape.<br><br>The report provides comprehensive information on the therapeutics under development for Traveler&#039;s Diarrhea, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.<br><br>The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.<br><br>The report is built using data and information sourced from Global Markets Direct’s proprietary d...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226700"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 12 Jul 2022 14:45:37 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players]]></title>
      <link>https://www.leadingmarketresearch.com/chemotherapy-induced-diarrhea-cid-drugs-in-development-by-stages-target</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chemotherapy-Induced Diarrhea (CID) pipeline landscape.<br><br>The report provides comprehensive information on the therapeutics under development for Chemotherapy-Induced Diarrhea (CID), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.<br><br>The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.<br><br>The report is built using data and information sourced from Global...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226905"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 12 Jul 2022 14:45:37 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/diarrhea-drugs-in-development-by-stages-target-moa-roa-molecule-type-an</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.<br><br>Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mech...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-222253"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 08 Apr 2022 11:35:28 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diarrhea Global Clinical Trials Review, H1, 2020]]></title>
      <link>https://www.leadingmarketresearch.com/diarrhea-global-clinical-trials-review-h1-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2020&quot; provides an overview of Diarrhea Clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. <br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain compet...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-213687"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 24 Feb 2020 15:56:48 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diarrhea - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/diarrhea-pipeline-review-h1-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Pipeline Review, H1 2019, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.<br><br>Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the t...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208038"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diarrhea Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/diarrhea-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Diarrhea Global Clinical Trials Review, H2, 2016&quot; provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<br><br>*N...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-187594"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Jan 2017 15:23:53 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diarrhea - Pipeline Review, H2 2016]]></title>
      <link>https://www.leadingmarketresearch.com/diarrhea-pipeline-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct’s, ‘Diarrhea - Pipeline Review, H2 2016’, provides an overview of the Diarrhea pipeline landscape. <br><br>The report provides comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. <br><br>Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured pres...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-184604"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Sep 2016 21:22:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diarrhea - Pipeline Review, H1 2016]]></title>
      <link>https://www.leadingmarketresearch.com/diarrhea-pipeline-review-h1-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct’s, ‘Diarrhea - Pipeline Review, H1 2016’, provides an overview of the Diarrhea pipeline landscape. <br><br>The report provides comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. <br><br>Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured pres...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-173924"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Sun, 29 May 2016 12:24:04 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Traveler&#039;s Diarrhea - Pipeline Review, H1 2016]]></title>
      <link>https://www.leadingmarketresearch.com/traveler-039-s-diarrhea-pipeline-review-h1-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct’s, ‘Traveler&#039;s Diarrhea - Pipeline Review, H1 2016’, provides an overview of the Traveler&#039;s Diarrhea pipeline landscape. <br><br>The report provides comprehensive information on the therapeutics under development for Traveler&#039;s Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Traveler&#039;s Diarrhea and features dormant and discontinued projects. <br><br>Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, co...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-173853"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Sat, 28 May 2016 19:12:44 +0000</pubDate>
    </item>
  </channel>
</rss>
